Bayesian Capital Management LP bought a new stake in MaxLinear, Inc. (NASDAQ:MXL - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 45,143 shares of the semiconductor company's stock, valued at approximately $893,000. Bayesian Capital Management LP owned approximately 0.05% of MaxLinear as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. The Manufacturers Life Insurance Company grew its position in shares of MaxLinear by 3,698.1% during the fourth quarter. The Manufacturers Life Insurance Company now owns 1,525,419 shares of the semiconductor company's stock worth $30,173,000 after acquiring an additional 1,485,256 shares during the last quarter. Schonfeld Strategic Advisors LLC bought a new stake in MaxLinear during the fourth quarter worth approximately $25,027,000. Assenagon Asset Management S.A. raised its stake in shares of MaxLinear by 339.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,250,769 shares of the semiconductor company's stock worth $24,740,000 after buying an additional 966,468 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of MaxLinear by 422.1% in the fourth quarter. Victory Capital Management Inc. now owns 815,931 shares of the semiconductor company's stock valued at $16,139,000 after buying an additional 659,662 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in MaxLinear by 44.6% during the third quarter. JPMorgan Chase & Co. now owns 935,739 shares of the semiconductor company's stock worth $13,550,000 after acquiring an additional 288,607 shares during the period. 90.79% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on MXL shares. Loop Capital dropped their price target on MaxLinear from $18.00 to $10.00 and set a "hold" rating on the stock in a research note on Tuesday, April 29th. Benchmark reissued a "buy" rating and set a $20.00 target price on shares of MaxLinear in a research note on Thursday, April 24th. Roth Capital set a $11.00 price objective on MaxLinear and gave the stock a "neutral" rating in a research note on Thursday, April 24th. Stifel Nicolaus lowered their price objective on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating on the stock in a research report on Thursday, April 17th. Finally, Wells Fargo & Company increased their target price on shares of MaxLinear from $19.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 30th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, MaxLinear presently has a consensus rating of "Hold" and a consensus target price of $19.06.
Check Out Our Latest Stock Report on MaxLinear
MaxLinear Price Performance
MXL stock traded up $0.12 during trading on Friday, hitting $11.34. 644,681 shares of the stock traded hands, compared to its average volume of 1,428,334. The stock has a market cap of $959.75 million, a price-to-earnings ratio of -3.87 and a beta of 1.66. MaxLinear, Inc. has a one year low of $8.35 and a one year high of $26.59. The company has a 50 day simple moving average of $11.17 and a 200 day simple moving average of $15.50. The company has a current ratio of 1.77, a quick ratio of 1.28 and a debt-to-equity ratio of 0.24.
MaxLinear (NASDAQ:MXL - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05). The business had revenue of $95.93 million for the quarter, compared to analysts' expectations of $95.32 million. MaxLinear had a negative net margin of 68.01% and a negative return on equity of 21.94%. MaxLinear's revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.21) earnings per share. Equities analysts expect that MaxLinear, Inc. will post -0.37 EPS for the current fiscal year.
Insider Activity at MaxLinear
In other news, Director Ted L. Tewksbury III sold 6,071 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $10.40, for a total value of $63,138.40. Following the transaction, the director now owns 74,995 shares in the company, valued at approximately $779,948. The trade was a 7.49 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 7.80% of the stock is owned by insiders.
MaxLinear Profile
(
Free Report)
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Further Reading

Before you consider MaxLinear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.
While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.